Myopic Choroidal Neovascularization

Also known as: Choroidal neovascularisation / Choroidal neovascularization / Myopic choroidal neovascularisation

DrugDrug NameDrug Description
DB08885AfliberceptA vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy.
DB01270RanibizumabA recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema.
DrugDrug NamePhaseStatusCount
DB01270Ranibizumab4Unknown Status1
DB08885AfliberceptNot AvailableCompleted1